Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ

Latest Articles

  • Free
    Editorial
    Acknowledgment of Ad Hoc Reviewers
    Marcela F. Pasetti
  • Vaccines | Spotlight
    Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax
    Wilbur H. Chen, Marcela F. Pasetti, Rajan P. Adhikari, Holly Baughman, Robin Douglas, Jill El-Khorazaty, Nancy Greenberg, Frederick W. Holtsberg, Grant C. Liao, Mardi K. Reymann, Xiaolin Wang, Kelly L. Warfield, M. Javad Aman
  • Free
    Commentary
    Shigella Vaccine Development: Finding the Path of Least Resistance
    Wilbur H. Chen, Karen L. Kotloff
  • Clinical Immunology | Spotlight
    In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes
    Siroon Bekkering, Bastiaan A. Blok, Leo A. B. Joosten, Niels P. Riksen, Reinout van Crevel, Mihai G. Netea
  • Vaccines
    Induction of Robust Immune Responses in Swine by Using a Cocktail of Adenovirus-Vectored African Swine Fever Virus Antigens
    Shehnaz Lokhandwala, Suryakant D. Waghela, Jocelyn Bray, Cameron L. Martin, Neha Sangewar, Chloe Charendoff, Rashmi Shetti, Clay Ashley, Chang-Hsin Chen, Luc R. Berghman, Duncan Mwangi, Paul J. Dominowski, Dennis L. Foss, Sharath Rai, Shaunak Vora, Lindsay Gabbert, Thomas G. Burrage, David Brake, John Neilan, Waithaka Mwangi
  • Vaccines
    Antibody Responses to Immunizations in Children with Type I Diabetes Mellitus: a Case-Control Study
    Michael Eisenhut, Alexander Chesover, Ronald Misquith, Nisha Nathwani, Andrew Walters
  • Free
    Spotlight
    Articles of Significant Interest Selected from This Issue by the Editors
  • Clinical Immunology
    Small-Volume Adenosine, Lidocaine, and Mg2+ 4-Hour Infusion Leads to 88% Survival after 6 Days of Experimental Sepsis in the Rat without Antibiotics
    Maddison Jade Griffin, Hayley Louise Letson, Geoffrey Phillip Dobson
  • Clinical Immunology | Spotlight
    Synergistic Neutralization of Pertussis Toxin by a Bispecific Antibody In Vitro and In Vivo
    Ellen K. Wagner, Xianzhe Wang, Andre Bui, Jennifer A. Maynard
  • Clinical Immunology
    Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life
    Igor C. Borges, Dafne C. Andrade, Maria Regina A. Cardoso, Jorma Toppari, Mari Vähä-Mäkilä, Jorma Ilonen, Mikael Knip, Heikki Hyöty, Riitta Veijola, Olli Simell, Tuomas Jartti, Helena Käyhty, Olli Ruuskanen, Cristiana M. Nascimento-Carvalho

Pages

  • ‹ previous
  • next ›
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 452
Back to top

About CVI

Clinical and Vaccine Immunology® (CVI) published articles that enhanced the understanding of the immune response in health and disease and after vaccination by showcasing discoveries in clinical, laboratory, and vaccine immunology.

As of January 2018, research in this area is published by ASM's multi-disciplinary, open access journal mSphere®.

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X